Overview
- 7 FDA inspections are on record.
- 5 inspections produced a Form 483.
- The most recent recorded inspection date is 2026-04-20.
At a glance
Inspections
7
Form 483s
5
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 14 Apr 2026 – 20 Apr 2026 | Human Drugs | 483 | On file |
| 8 Nov 2021 – 16 Nov 2021 | Human Drugs | 483 | On file |
| 11 Oct 2016 – 12 Oct 2016 | Human Drugs | 483 | On file |
| 29 Apr 2013 – 1 May 2013 | Foods & Cosmetics | Clean | |
| 10 Feb 2010 | Not recorded | 483 | View 483 → |
| 15 Sep 2008 | Not recorded | 483 | On file |
| 9 Dec 2005 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
10 Feb 2010
21 CFR 211.100(b)
SOPs not followed / documented
Cited by Robert M Barbosa, Daniel J Gorski
10 Feb 2010
21 CFR 211.160(a)
Following/documenting laboratory controls
Cited by Robert M Barbosa, Daniel J Gorski
Investigators
FDA investigators tied to this site in the record.
Muna Algharibeh2 insp.
Eboni S Funderburk1 insp.
Meisha R Sampson1 insp.
Emily J Orban1 insp.
Robert M Barbosa1 insp.
Daniel J Gorski1 insp.
Rebecca E Dombrowski1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.100(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.25(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Nice-Pak Products, Inc.'s 5 Form 483s
Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat